Radiotherapy plus cetuximab or cisplatin in human papilloma-virus positive oropharyngeal cancer (NRG 1016): A randomized multicenter noninferiority trial Ridge, J. A., Ringash, J., Yao, M., Blakaj, D. M., Razaq, M. A., Colevas, A. D., Beitler, J. J., Jones, C. U., Dunlap, N. E., Seaward, S. A., Spencer, S., Galloway, T. J., Dignam, J. J., Le, Q. T., Gillison, M. L., Sturgis, E. M., Phan, J., Trotti, A. M., Harris, J., Eisbruch, A., Harari, P. M., Adelstein, D. J., Koyfman, S. A., Burtness, B. AMER ASSOC CANCER RESEARCH. 2020: 21–22

View details for Web of Science ID 000541829900015